 "Over 200,000 SARS-CoV-2 genomes sequenced by INSACOG, says govt")
Over two lakh SARS-CoV-2 genomes have been sequenced by the Indian SARS-COV-2 Genomics Consortia (INSACOG), the government said on Wednesday.
Responding to a question in Lok Sabha, Minister of State for Science and Technology Jitendra Singh said 17 COVID-19 bio-repositories have been notified by the government.
These have been set up at the laboratories of the Department of Biotechnology, the Council of Scientific and Industrial Research, and the Indian Council of Medical Research.
"The Indian SARS-CoV-2 Genomics Consortium (INSACOG) being coordinated by the Department of Biotechnology, as on March 23, 2022, has sequenced 2,01,373 SARS-CoV-2 genomes," Singh said in a written response.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app